nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—PTGS2—Barrett's esophagus	0.592	1	CbGaD
Lenalidomide—ABCB1—Omeprazole—Barrett's esophagus	0.0466	1	CbGbCtD
Lenalidomide—TNFSF11—Osteoclast Signaling—SLC9A1—Barrett's esophagus	0.0192	0.192	CbGpPWpGaD
Lenalidomide—CDH5—Adherens junctions interactions—CDH13—Barrett's esophagus	0.0143	0.144	CbGpPWpGaD
Lenalidomide—TNFSF11—IL6-mediated signaling events—MCL1—Barrett's esophagus	0.0123	0.123	CbGpPWpGaD
Lenalidomide—TNFSF11—Differentiation Pathway—BMP4—Barrett's esophagus	0.00836	0.0839	CbGpPWpGaD
Lenalidomide—CDH5—Cell-cell junction organization—CDH13—Barrett's esophagus	0.00823	0.0825	CbGpPWpGaD
Lenalidomide—CDH5—Cell junction organization—CDH13—Barrett's esophagus	0.00623	0.0624	CbGpPWpGaD
Lenalidomide—TNFSF11—Differentiation Pathway—HGF—Barrett's esophagus	0.00507	0.0508	CbGpPWpGaD
Lenalidomide—CDH5—epithelium—Barrett's esophagus	0.00464	0.322	CbGeAlD
Lenalidomide—CDH5—smooth muscle tissue—Barrett's esophagus	0.00447	0.31	CbGeAlD
Lenalidomide—CDH5—Cell-Cell communication—CDH13—Barrett's esophagus	0.00443	0.0445	CbGpPWpGaD
Lenalidomide—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—Barrett's esophagus	0.00399	0.04	CbGpPWpGaD
Lenalidomide—Pomalidomide—PTGS2—Barrett's esophagus	0.00285	0.608	CrCbGaD
Lenalidomide—TNFSF11—RANKL/RANK Signaling Pathway—RELA—Barrett's esophagus	0.00264	0.0264	CbGpPWpGaD
Lenalidomide—PTGS2—Eicosanoid Synthesis—PTGES—Barrett's esophagus	0.00259	0.026	CbGpPWpGaD
Lenalidomide—CRBN—digestive system—Barrett's esophagus	0.00224	0.156	CbGeAlD
Lenalidomide—Thalidomide—PTGS2—Barrett's esophagus	0.00184	0.392	CrCbGaD
Lenalidomide—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00183	0.0184	CbGpPWpGaD
Lenalidomide—PTGS2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00144	0.0145	CbGpPWpGaD
Lenalidomide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00105	0.0106	CbGpPWpGaD
Lenalidomide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00105	0.0106	CbGpPWpGaD
Lenalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—SLC9A1—Barrett's esophagus	0.00105	0.0105	CbGpPWpGaD
Lenalidomide—PTGS2—epithelium—Barrett's esophagus	0.000803	0.0557	CbGeAlD
Lenalidomide—PTGS2—smooth muscle tissue—Barrett's esophagus	0.000774	0.0536	CbGeAlD
Lenalidomide—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.000713	0.00294	CcSEcCtD
Lenalidomide—Diplopia—Esomeprazole—Barrett's esophagus	0.000713	0.00294	CcSEcCtD
Lenalidomide—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.000713	0.00294	CcSEcCtD
Lenalidomide—Diplopia—Omeprazole—Barrett's esophagus	0.000713	0.00294	CcSEcCtD
Lenalidomide—Migraine—Esomeprazole—Barrett's esophagus	0.000701	0.00289	CcSEcCtD
Lenalidomide—Migraine—Omeprazole—Barrett's esophagus	0.000701	0.00289	CcSEcCtD
Lenalidomide—Face oedema—Omeprazole—Barrett's esophagus	0.000688	0.00284	CcSEcCtD
Lenalidomide—Face oedema—Esomeprazole—Barrett's esophagus	0.000688	0.00284	CcSEcCtD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000678	0.0068	CbGpPWpGaD
Lenalidomide—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.000668	0.00275	CcSEcCtD
Lenalidomide—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.000668	0.00275	CcSEcCtD
Lenalidomide—Dry skin—Omeprazole—Barrett's esophagus	0.000653	0.0027	CcSEcCtD
Lenalidomide—Dry skin—Esomeprazole—Barrett's esophagus	0.000653	0.0027	CcSEcCtD
Lenalidomide—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.000651	0.00269	CcSEcCtD
Lenalidomide—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.000651	0.00269	CcSEcCtD
Lenalidomide—Hypokalaemia—Omeprazole—Barrett's esophagus	0.000649	0.00268	CcSEcCtD
Lenalidomide—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.000649	0.00268	CcSEcCtD
Lenalidomide—Breast disorder—Esomeprazole—Barrett's esophagus	0.000644	0.00266	CcSEcCtD
Lenalidomide—Breast disorder—Omeprazole—Barrett's esophagus	0.000644	0.00266	CcSEcCtD
Lenalidomide—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.000642	0.00265	CcSEcCtD
Lenalidomide—Cramp muscle—Esomeprazole—Barrett's esophagus	0.000642	0.00265	CcSEcCtD
Lenalidomide—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.000642	0.00265	CcSEcCtD
Lenalidomide—Cramp muscle—Omeprazole—Barrett's esophagus	0.000642	0.00265	CcSEcCtD
Lenalidomide—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000642	0.00265	CcSEcCtD
Lenalidomide—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.000642	0.00265	CcSEcCtD
Lenalidomide—Gastritis—Omeprazole—Barrett's esophagus	0.000631	0.0026	CcSEcCtD
Lenalidomide—Gastritis—Esomeprazole—Barrett's esophagus	0.000631	0.0026	CcSEcCtD
Lenalidomide—Muscular weakness—Esomeprazole—Barrett's esophagus	0.000628	0.00259	CcSEcCtD
Lenalidomide—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000628	0.00259	CcSEcCtD
Lenalidomide—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.000628	0.00259	CcSEcCtD
Lenalidomide—Muscular weakness—Omeprazole—Barrett's esophagus	0.000628	0.00259	CcSEcCtD
Lenalidomide—Abdominal distension—Esomeprazole—Barrett's esophagus	0.00062	0.00256	CcSEcCtD
Lenalidomide—Abdominal distension—Omeprazole—Barrett's esophagus	0.00062	0.00256	CcSEcCtD
Lenalidomide—Asthma—Omeprazole—Barrett's esophagus	0.000616	0.00254	CcSEcCtD
Lenalidomide—Influenza—Omeprazole—Barrett's esophagus	0.000616	0.00254	CcSEcCtD
Lenalidomide—Dysphagia—Esomeprazole—Barrett's esophagus	0.000616	0.00254	CcSEcCtD
Lenalidomide—Asthma—Esomeprazole—Barrett's esophagus	0.000616	0.00254	CcSEcCtD
Lenalidomide—Dysphagia—Omeprazole—Barrett's esophagus	0.000616	0.00254	CcSEcCtD
Lenalidomide—Influenza—Esomeprazole—Barrett's esophagus	0.000616	0.00254	CcSEcCtD
Lenalidomide—PTGS2—digestive system—Barrett's esophagus	0.000611	0.0424	CbGeAlD
Lenalidomide—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000604	0.00249	CcSEcCtD
Lenalidomide—Pancreatitis—Omeprazole—Barrett's esophagus	0.000604	0.00249	CcSEcCtD
Lenalidomide—Angina pectoris—Omeprazole—Barrett's esophagus	0.0006	0.00248	CcSEcCtD
Lenalidomide—Angina pectoris—Esomeprazole—Barrett's esophagus	0.0006	0.00248	CcSEcCtD
Lenalidomide—Sweating increased—Esomeprazole—Barrett's esophagus	0.0006	0.00248	CcSEcCtD
Lenalidomide—Sweating increased—Omeprazole—Barrett's esophagus	0.0006	0.00248	CcSEcCtD
Lenalidomide—PTGS2—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.000594	0.00596	CbGpPWpGaD
Lenalidomide—Pancytopenia—Omeprazole—Barrett's esophagus	0.000585	0.00241	CcSEcCtD
Lenalidomide—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000585	0.00241	CcSEcCtD
Lenalidomide—Neutropenia—Omeprazole—Barrett's esophagus	0.000576	0.00238	CcSEcCtD
Lenalidomide—Dysuria—Omeprazole—Barrett's esophagus	0.000576	0.00238	CcSEcCtD
Lenalidomide—Dysuria—Esomeprazole—Barrett's esophagus	0.000576	0.00238	CcSEcCtD
Lenalidomide—Neutropenia—Esomeprazole—Barrett's esophagus	0.000576	0.00238	CcSEcCtD
Lenalidomide—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000572	0.00236	CcSEcCtD
Lenalidomide—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000572	0.00236	CcSEcCtD
Lenalidomide—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000569	0.00235	CcSEcCtD
Lenalidomide—Pollakiuria—Omeprazole—Barrett's esophagus	0.000569	0.00235	CcSEcCtD
Lenalidomide—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.000567	0.00234	CcSEcCtD
Lenalidomide—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.000567	0.00234	CcSEcCtD
Lenalidomide—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000562	0.00232	CcSEcCtD
Lenalidomide—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000562	0.00232	CcSEcCtD
Lenalidomide—Weight increased—Omeprazole—Barrett's esophagus	0.00056	0.00231	CcSEcCtD
Lenalidomide—Weight increased—Esomeprazole—Barrett's esophagus	0.00056	0.00231	CcSEcCtD
Lenalidomide—Weight decreased—Omeprazole—Barrett's esophagus	0.000557	0.0023	CcSEcCtD
Lenalidomide—Weight decreased—Esomeprazole—Barrett's esophagus	0.000557	0.0023	CcSEcCtD
Lenalidomide—Infestation NOS—Omeprazole—Barrett's esophagus	0.000549	0.00227	CcSEcCtD
Lenalidomide—Infestation—Omeprazole—Barrett's esophagus	0.000549	0.00227	CcSEcCtD
Lenalidomide—Infestation NOS—Esomeprazole—Barrett's esophagus	0.000549	0.00227	CcSEcCtD
Lenalidomide—Infestation—Esomeprazole—Barrett's esophagus	0.000549	0.00227	CcSEcCtD
Lenalidomide—Depression—Esomeprazole—Barrett's esophagus	0.000548	0.00226	CcSEcCtD
Lenalidomide—Depression—Omeprazole—Barrett's esophagus	0.000548	0.00226	CcSEcCtD
Lenalidomide—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000544	0.00225	CcSEcCtD
Lenalidomide—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000544	0.00225	CcSEcCtD
Lenalidomide—Renal failure—Esomeprazole—Barrett's esophagus	0.00054	0.00223	CcSEcCtD
Lenalidomide—Renal failure—Omeprazole—Barrett's esophagus	0.00054	0.00223	CcSEcCtD
Lenalidomide—Stomatitis—Esomeprazole—Barrett's esophagus	0.000535	0.00221	CcSEcCtD
Lenalidomide—Stomatitis—Omeprazole—Barrett's esophagus	0.000535	0.00221	CcSEcCtD
Lenalidomide—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000534	0.0022	CcSEcCtD
Lenalidomide—Urinary tract infection—Omeprazole—Barrett's esophagus	0.000534	0.0022	CcSEcCtD
Lenalidomide—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.000534	0.0022	CcSEcCtD
Lenalidomide—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000534	0.0022	CcSEcCtD
Lenalidomide—Haematuria—Omeprazole—Barrett's esophagus	0.000524	0.00216	CcSEcCtD
Lenalidomide—Haematuria—Esomeprazole—Barrett's esophagus	0.000524	0.00216	CcSEcCtD
Lenalidomide—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000519	0.00214	CcSEcCtD
Lenalidomide—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000519	0.00214	CcSEcCtD
Lenalidomide—Epistaxis—Esomeprazole—Barrett's esophagus	0.000518	0.00214	CcSEcCtD
Lenalidomide—Epistaxis—Omeprazole—Barrett's esophagus	0.000518	0.00214	CcSEcCtD
Lenalidomide—Sinusitis—Esomeprazole—Barrett's esophagus	0.000515	0.00213	CcSEcCtD
Lenalidomide—Sinusitis—Omeprazole—Barrett's esophagus	0.000515	0.00213	CcSEcCtD
Lenalidomide—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000512	0.00211	CcSEcCtD
Lenalidomide—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000512	0.00211	CcSEcCtD
Lenalidomide—Bradycardia—Omeprazole—Barrett's esophagus	0.000502	0.00207	CcSEcCtD
Lenalidomide—Bradycardia—Esomeprazole—Barrett's esophagus	0.000502	0.00207	CcSEcCtD
Lenalidomide—ABCB1—epithelium—Barrett's esophagus	0.000497	0.0344	CbGeAlD
Lenalidomide—Rhinitis—Omeprazole—Barrett's esophagus	0.000494	0.00204	CcSEcCtD
Lenalidomide—Rhinitis—Esomeprazole—Barrett's esophagus	0.000494	0.00204	CcSEcCtD
Lenalidomide—Hepatitis—Esomeprazole—Barrett's esophagus	0.000493	0.00203	CcSEcCtD
Lenalidomide—Hepatitis—Omeprazole—Barrett's esophagus	0.000493	0.00203	CcSEcCtD
Lenalidomide—Hallucination—Omeprazole—Barrett's esophagus	0.00049	0.00202	CcSEcCtD
Lenalidomide—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.00049	0.00202	CcSEcCtD
Lenalidomide—Hallucination—Esomeprazole—Barrett's esophagus	0.00049	0.00202	CcSEcCtD
Lenalidomide—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.00049	0.00202	CcSEcCtD
Lenalidomide—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000489	0.00202	CcSEcCtD
Lenalidomide—Pharyngitis—Omeprazole—Barrett's esophagus	0.000489	0.00202	CcSEcCtD
Lenalidomide—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000487	0.00201	CcSEcCtD
Lenalidomide—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000487	0.00201	CcSEcCtD
Lenalidomide—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000486	0.002	CcSEcCtD
Lenalidomide—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000486	0.002	CcSEcCtD
Lenalidomide—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.000484	0.002	CcSEcCtD
Lenalidomide—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.000484	0.002	CcSEcCtD
Lenalidomide—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000483	0.00199	CcSEcCtD
Lenalidomide—Urethral disorder—Omeprazole—Barrett's esophagus	0.000483	0.00199	CcSEcCtD
Lenalidomide—Visual impairment—Omeprazole—Barrett's esophagus	0.000475	0.00196	CcSEcCtD
Lenalidomide—Visual impairment—Esomeprazole—Barrett's esophagus	0.000475	0.00196	CcSEcCtD
Lenalidomide—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000466	0.00192	CcSEcCtD
Lenalidomide—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000466	0.00192	CcSEcCtD
Lenalidomide—Eye disorder—Omeprazole—Barrett's esophagus	0.000461	0.0019	CcSEcCtD
Lenalidomide—Eye disorder—Esomeprazole—Barrett's esophagus	0.000461	0.0019	CcSEcCtD
Lenalidomide—Tinnitus—Omeprazole—Barrett's esophagus	0.00046	0.0019	CcSEcCtD
Lenalidomide—Tinnitus—Esomeprazole—Barrett's esophagus	0.00046	0.0019	CcSEcCtD
Lenalidomide—Flushing—Esomeprazole—Barrett's esophagus	0.000458	0.00189	CcSEcCtD
Lenalidomide—Flushing—Omeprazole—Barrett's esophagus	0.000458	0.00189	CcSEcCtD
Lenalidomide—Immune system disorder—Omeprazole—Barrett's esophagus	0.000445	0.00184	CcSEcCtD
Lenalidomide—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000445	0.00184	CcSEcCtD
Lenalidomide—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000444	0.00183	CcSEcCtD
Lenalidomide—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000444	0.00183	CcSEcCtD
Lenalidomide—Chills—Esomeprazole—Barrett's esophagus	0.000442	0.00183	CcSEcCtD
Lenalidomide—Chills—Omeprazole—Barrett's esophagus	0.000442	0.00183	CcSEcCtD
Lenalidomide—Alopecia—Omeprazole—Barrett's esophagus	0.000436	0.0018	CcSEcCtD
Lenalidomide—Alopecia—Esomeprazole—Barrett's esophagus	0.000436	0.0018	CcSEcCtD
Lenalidomide—Mental disorder—Omeprazole—Barrett's esophagus	0.000432	0.00178	CcSEcCtD
Lenalidomide—Mental disorder—Esomeprazole—Barrett's esophagus	0.000432	0.00178	CcSEcCtD
Lenalidomide—Malnutrition—Esomeprazole—Barrett's esophagus	0.000429	0.00177	CcSEcCtD
Lenalidomide—Malnutrition—Omeprazole—Barrett's esophagus	0.000429	0.00177	CcSEcCtD
Lenalidomide—Flatulence—Omeprazole—Barrett's esophagus	0.000423	0.00175	CcSEcCtD
Lenalidomide—Flatulence—Esomeprazole—Barrett's esophagus	0.000423	0.00175	CcSEcCtD
Lenalidomide—Tension—Esomeprazole—Barrett's esophagus	0.000421	0.00174	CcSEcCtD
Lenalidomide—Tension—Omeprazole—Barrett's esophagus	0.000421	0.00174	CcSEcCtD
Lenalidomide—Dysgeusia—Omeprazole—Barrett's esophagus	0.00042	0.00173	CcSEcCtD
Lenalidomide—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00042	0.00173	CcSEcCtD
Lenalidomide—Nervousness—Esomeprazole—Barrett's esophagus	0.000417	0.00172	CcSEcCtD
Lenalidomide—Nervousness—Omeprazole—Barrett's esophagus	0.000417	0.00172	CcSEcCtD
Lenalidomide—Back pain—Omeprazole—Barrett's esophagus	0.000415	0.00171	CcSEcCtD
Lenalidomide—Back pain—Esomeprazole—Barrett's esophagus	0.000415	0.00171	CcSEcCtD
Lenalidomide—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000413	0.0017	CcSEcCtD
Lenalidomide—Muscle spasms—Omeprazole—Barrett's esophagus	0.000413	0.0017	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—GAST—Barrett's esophagus	0.000405	0.00406	CbGpPWpGaD
Lenalidomide—Vision blurred—Omeprazole—Barrett's esophagus	0.000404	0.00167	CcSEcCtD
Lenalidomide—Vision blurred—Esomeprazole—Barrett's esophagus	0.000404	0.00167	CcSEcCtD
Lenalidomide—Tremor—Omeprazole—Barrett's esophagus	0.000402	0.00166	CcSEcCtD
Lenalidomide—Tremor—Esomeprazole—Barrett's esophagus	0.000402	0.00166	CcSEcCtD
Lenalidomide—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000398	0.00164	CcSEcCtD
Lenalidomide—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000398	0.00164	CcSEcCtD
Lenalidomide—Anaemia—Esomeprazole—Barrett's esophagus	0.000397	0.00164	CcSEcCtD
Lenalidomide—Anaemia—Omeprazole—Barrett's esophagus	0.000397	0.00164	CcSEcCtD
Lenalidomide—Agitation—Esomeprazole—Barrett's esophagus	0.000394	0.00163	CcSEcCtD
Lenalidomide—Agitation—Omeprazole—Barrett's esophagus	0.000394	0.00163	CcSEcCtD
Lenalidomide—Angioedema—Esomeprazole—Barrett's esophagus	0.000392	0.00162	CcSEcCtD
Lenalidomide—Angioedema—Omeprazole—Barrett's esophagus	0.000392	0.00162	CcSEcCtD
Lenalidomide—Malaise—Omeprazole—Barrett's esophagus	0.000387	0.0016	CcSEcCtD
Lenalidomide—Malaise—Esomeprazole—Barrett's esophagus	0.000387	0.0016	CcSEcCtD
Lenalidomide—Vertigo—Esomeprazole—Barrett's esophagus	0.000386	0.00159	CcSEcCtD
Lenalidomide—Vertigo—Omeprazole—Barrett's esophagus	0.000386	0.00159	CcSEcCtD
Lenalidomide—Leukopenia—Esomeprazole—Barrett's esophagus	0.000384	0.00159	CcSEcCtD
Lenalidomide—Leukopenia—Omeprazole—Barrett's esophagus	0.000384	0.00159	CcSEcCtD
Lenalidomide—Palpitations—Omeprazole—Barrett's esophagus	0.000379	0.00156	CcSEcCtD
Lenalidomide—Palpitations—Esomeprazole—Barrett's esophagus	0.000379	0.00156	CcSEcCtD
Lenalidomide—ABCB1—digestive system—Barrett's esophagus	0.000378	0.0262	CbGeAlD
Lenalidomide—Cough—Esomeprazole—Barrett's esophagus	0.000374	0.00155	CcSEcCtD
Lenalidomide—Cough—Omeprazole—Barrett's esophagus	0.000374	0.00155	CcSEcCtD
Lenalidomide—Hypertension—Omeprazole—Barrett's esophagus	0.00037	0.00153	CcSEcCtD
Lenalidomide—Hypertension—Esomeprazole—Barrett's esophagus	0.00037	0.00153	CcSEcCtD
Lenalidomide—Chest pain—Omeprazole—Barrett's esophagus	0.000365	0.00151	CcSEcCtD
Lenalidomide—Myalgia—Omeprazole—Barrett's esophagus	0.000365	0.00151	CcSEcCtD
Lenalidomide—Arthralgia—Esomeprazole—Barrett's esophagus	0.000365	0.00151	CcSEcCtD
Lenalidomide—Myalgia—Esomeprazole—Barrett's esophagus	0.000365	0.00151	CcSEcCtD
Lenalidomide—Arthralgia—Omeprazole—Barrett's esophagus	0.000365	0.00151	CcSEcCtD
Lenalidomide—Chest pain—Esomeprazole—Barrett's esophagus	0.000365	0.00151	CcSEcCtD
Lenalidomide—Anxiety—Omeprazole—Barrett's esophagus	0.000364	0.0015	CcSEcCtD
Lenalidomide—Anxiety—Esomeprazole—Barrett's esophagus	0.000364	0.0015	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000363	0.0015	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000363	0.0015	CcSEcCtD
Lenalidomide—Discomfort—Esomeprazole—Barrett's esophagus	0.000361	0.00149	CcSEcCtD
Lenalidomide—Discomfort—Omeprazole—Barrett's esophagus	0.000361	0.00149	CcSEcCtD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—Barrett's esophagus	0.000359	0.0036	CbGpPWpGaD
Lenalidomide—Dry mouth—Esomeprazole—Barrett's esophagus	0.000357	0.00147	CcSEcCtD
Lenalidomide—Dry mouth—Omeprazole—Barrett's esophagus	0.000357	0.00147	CcSEcCtD
Lenalidomide—Confusional state—Omeprazole—Barrett's esophagus	0.000353	0.00146	CcSEcCtD
Lenalidomide—Confusional state—Esomeprazole—Barrett's esophagus	0.000353	0.00146	CcSEcCtD
Lenalidomide—Infection—Omeprazole—Barrett's esophagus	0.000348	0.00144	CcSEcCtD
Lenalidomide—Infection—Esomeprazole—Barrett's esophagus	0.000348	0.00144	CcSEcCtD
Lenalidomide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000347	0.00348	CbGpPWpGaD
Lenalidomide—Shock—Esomeprazole—Barrett's esophagus	0.000345	0.00142	CcSEcCtD
Lenalidomide—Shock—Omeprazole—Barrett's esophagus	0.000345	0.00142	CcSEcCtD
Lenalidomide—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000343	0.00142	CcSEcCtD
Lenalidomide—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000343	0.00142	CcSEcCtD
Lenalidomide—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000343	0.00142	CcSEcCtD
Lenalidomide—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000343	0.00142	CcSEcCtD
Lenalidomide—Tachycardia—Esomeprazole—Barrett's esophagus	0.000342	0.00141	CcSEcCtD
Lenalidomide—Tachycardia—Omeprazole—Barrett's esophagus	0.000342	0.00141	CcSEcCtD
Lenalidomide—Skin disorder—Omeprazole—Barrett's esophagus	0.00034	0.0014	CcSEcCtD
Lenalidomide—Skin disorder—Esomeprazole—Barrett's esophagus	0.00034	0.0014	CcSEcCtD
Lenalidomide—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000339	0.0014	CcSEcCtD
Lenalidomide—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000339	0.0014	CcSEcCtD
Lenalidomide—Anorexia—Omeprazole—Barrett's esophagus	0.000334	0.00138	CcSEcCtD
Lenalidomide—Anorexia—Esomeprazole—Barrett's esophagus	0.000334	0.00138	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000319	0.00132	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000319	0.00132	CcSEcCtD
Lenalidomide—Insomnia—Esomeprazole—Barrett's esophagus	0.000317	0.00131	CcSEcCtD
Lenalidomide—Insomnia—Omeprazole—Barrett's esophagus	0.000317	0.00131	CcSEcCtD
Lenalidomide—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000314	0.0013	CcSEcCtD
Lenalidomide—Paraesthesia—Omeprazole—Barrett's esophagus	0.000314	0.0013	CcSEcCtD
Lenalidomide—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000312	0.00129	CcSEcCtD
Lenalidomide—Dyspnoea—Omeprazole—Barrett's esophagus	0.000312	0.00129	CcSEcCtD
Lenalidomide—Somnolence—Esomeprazole—Barrett's esophagus	0.000311	0.00128	CcSEcCtD
Lenalidomide—Somnolence—Omeprazole—Barrett's esophagus	0.000311	0.00128	CcSEcCtD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000311	0.00312	CbGpPWpGaD
Lenalidomide—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000308	0.00127	CcSEcCtD
Lenalidomide—Dyspepsia—Omeprazole—Barrett's esophagus	0.000308	0.00127	CcSEcCtD
Lenalidomide—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000304	0.00126	CcSEcCtD
Lenalidomide—Decreased appetite—Omeprazole—Barrett's esophagus	0.000304	0.00126	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000302	0.00125	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000302	0.00125	CcSEcCtD
Lenalidomide—Fatigue—Esomeprazole—Barrett's esophagus	0.000302	0.00125	CcSEcCtD
Lenalidomide—Fatigue—Omeprazole—Barrett's esophagus	0.000302	0.00125	CcSEcCtD
Lenalidomide—Pain—Esomeprazole—Barrett's esophagus	0.000299	0.00124	CcSEcCtD
Lenalidomide—Pain—Omeprazole—Barrett's esophagus	0.000299	0.00124	CcSEcCtD
Lenalidomide—Constipation—Omeprazole—Barrett's esophagus	0.000299	0.00124	CcSEcCtD
Lenalidomide—Constipation—Esomeprazole—Barrett's esophagus	0.000299	0.00124	CcSEcCtD
Lenalidomide—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000289	0.00119	CcSEcCtD
Lenalidomide—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000289	0.00119	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000286	0.00118	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000286	0.00118	CcSEcCtD
Lenalidomide—Urticaria—Esomeprazole—Barrett's esophagus	0.000278	0.00115	CcSEcCtD
Lenalidomide—Urticaria—Omeprazole—Barrett's esophagus	0.000278	0.00115	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—SST—Barrett's esophagus	0.000278	0.00278	CbGpPWpGaD
Lenalidomide—Abdominal pain—Omeprazole—Barrett's esophagus	0.000277	0.00114	CcSEcCtD
Lenalidomide—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000277	0.00114	CcSEcCtD
Lenalidomide—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000277	0.00114	CcSEcCtD
Lenalidomide—Body temperature increased—Omeprazole—Barrett's esophagus	0.000277	0.00114	CcSEcCtD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	0.000274	0.00275	CbGpPWpGaD
Lenalidomide—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000258	0.00106	CcSEcCtD
Lenalidomide—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000258	0.00106	CcSEcCtD
Lenalidomide—Asthenia—Esomeprazole—Barrett's esophagus	0.000251	0.00104	CcSEcCtD
Lenalidomide—Asthenia—Omeprazole—Barrett's esophagus	0.000251	0.00104	CcSEcCtD
Lenalidomide—Pruritus—Omeprazole—Barrett's esophagus	0.000248	0.00102	CcSEcCtD
Lenalidomide—Pruritus—Esomeprazole—Barrett's esophagus	0.000248	0.00102	CcSEcCtD
Lenalidomide—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00024	0.000989	CcSEcCtD
Lenalidomide—Diarrhoea—Omeprazole—Barrett's esophagus	0.00024	0.000989	CcSEcCtD
Lenalidomide—Dizziness—Omeprazole—Barrett's esophagus	0.000232	0.000956	CcSEcCtD
Lenalidomide—Dizziness—Esomeprazole—Barrett's esophagus	0.000232	0.000956	CcSEcCtD
Lenalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.000224	0.00224	CbGpPWpGaD
Lenalidomide—Vomiting—Omeprazole—Barrett's esophagus	0.000223	0.000919	CcSEcCtD
Lenalidomide—Vomiting—Esomeprazole—Barrett's esophagus	0.000223	0.000919	CcSEcCtD
Lenalidomide—Rash—Omeprazole—Barrett's esophagus	0.000221	0.000911	CcSEcCtD
Lenalidomide—Rash—Esomeprazole—Barrett's esophagus	0.000221	0.000911	CcSEcCtD
Lenalidomide—Dermatitis—Esomeprazole—Barrett's esophagus	0.000221	0.00091	CcSEcCtD
Lenalidomide—Dermatitis—Omeprazole—Barrett's esophagus	0.000221	0.00091	CcSEcCtD
Lenalidomide—Headache—Omeprazole—Barrett's esophagus	0.000219	0.000905	CcSEcCtD
Lenalidomide—Headache—Esomeprazole—Barrett's esophagus	0.000219	0.000905	CcSEcCtD
Lenalidomide—Nausea—Omeprazole—Barrett's esophagus	0.000208	0.000858	CcSEcCtD
Lenalidomide—Nausea—Esomeprazole—Barrett's esophagus	0.000208	0.000858	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000206	0.00207	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—CDKN2A—Barrett's esophagus	0.0002	0.002	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000185	0.00186	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—APC—Barrett's esophagus	0.000147	0.00147	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.000138	0.00138	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.000135	0.00135	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000127	0.00128	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000124	0.00124	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—RELA—Barrett's esophagus	0.000115	0.00115	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CXCL8—Barrett's esophagus	0.000108	0.00108	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PTGES—Barrett's esophagus	9.17e-05	0.00092	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	9.03e-05	0.000906	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TP53—Barrett's esophagus	8.46e-05	0.000849	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	7.58e-05	0.00076	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP26A1—Barrett's esophagus	6.95e-05	0.000697	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	6.86e-05	0.000688	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TP53—Barrett's esophagus	6.64e-05	0.000666	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGES—Barrett's esophagus	6.5e-05	0.000652	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SLC9A1—Barrett's esophagus	5.98e-05	0.0006	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	5.76e-05	0.000577	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	5.13e-05	0.000515	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC9A1—Barrett's esophagus	5.01e-05	0.000502	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	4.93e-05	0.000494	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.08e-05	0.000409	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	3.55e-05	0.000356	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APC—Barrett's esophagus	2.83e-05	0.000284	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPARG—Barrett's esophagus	2.29e-05	0.000229	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARG—Barrett's esophagus	1.62e-05	0.000163	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGS2—Barrett's esophagus	1.28e-05	0.000128	CbGpPWpGaD
